Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
2001 1
2002 4
2005 2
2006 3
2007 2
2008 3
2009 2
2010 5
2012 2
2013 3
2014 5
2015 10
2016 8
2017 12
2018 10
2019 9
2020 12
2021 13
2022 6
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
AVALON: The Italian cohort study on real-life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
Todisco E, Papayannidis C, Fracchiolla N, Petracci E, Zingaretti C, Vetro C, Martelli MP, Zappasodi P, Di Renzo N, Gallo S, Audisio E, Griguolo D, Cerchione C, Selleri C, Mattei D, Bernardi M, Fumagalli M, Rizzuto G, Facchini L, Basilico CM, Manfra I, Borlenghi E, Cairoli R, Salutari P, Gottardi M, Molteni A, Martini V, Lunghi M, Fianchi L, Cilloni D, Lanza F, Abruzzese E, Cascavilla N, Rivellini F, Ferrara F, Maurillo L, Nanni J, Romano A, Cardinali V, Gigli F, Roncoroni E, Federico V, Marconi G, Volpi R, Sciumè M, Tarella C, Rossi G, Martinelli G; AVALON Cooperative Group. Todisco E, et al. Among authors: gottardi m. Cancer. 2023 Apr 1;129(7):992-1004. doi: 10.1002/cncr.34608. Epub 2023 Jan 24. Cancer. 2023. PMID: 36692409 Free article.
Editorial: Inflammation and blood diseases, a dog chasing its tail.
Cumbo C, Tarantini F, Gottardi M, Albano F. Cumbo C, et al. Among authors: gottardi m. Front Oncol. 2023 Mar 24;13:1180559. doi: 10.3389/fonc.2023.1180559. eCollection 2023. Front Oncol. 2023. PMID: 37035144 Free PMC article. No abstract available.
Imatinib and hyperlipidemia.
Gottardi M, Manzato E, Gherlinzoni F. Gottardi M, et al. N Engl J Med. 2005 Dec 22;353(25):2722-3. doi: 10.1056/NEJMc052500. N Engl J Med. 2005. PMID: 16371644 No abstract available.
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin.
Gottardi M, Simonetti G, Sperotto A, Nappi D, Ghelli Luserna di Rorà A, Padella A, Norata M, Giannini MB, Musuraca G, Lanza F, Cerchione C, Martinelli G. Gottardi M, et al. Cancers (Basel). 2021 Sep 11;13(18):4566. doi: 10.3390/cancers13184566. Cancers (Basel). 2021. PMID: 34572794 Free PMC article. Review.
Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future.
Gottardi M, Sperotto A, Ghelli Luserna Di Rorà A, Padella A, Cangini D, Giannini MB, Simonetti G, Martinelli G, Cerchione C. Gottardi M, et al. Minerva Med. 2020 Oct;111(5):395-410. doi: 10.23736/S0026-4806.20.07019-6. Epub 2020 Sep 21. Minerva Med. 2020. PMID: 32955828 Free article. Review.
Screening of Strongyloides infection using an ELISA test in transplant candidates.
Toledo B, Corral MA, Meisel DMCL, Gottardi M, Abdala E, Costa SF, Pierrotti LC, Lescano SAZ, Gonçalves EMN, Castilho VLP, Chieffi PP, Gryschek RCB, Paula FM. Toledo B, et al. Among authors: gottardi m. Clinics (Sao Paulo). 2019;74:e698. doi: 10.6061/clinics/2019/e698. Epub 2019 Jun 6. Clinics (Sao Paulo). 2019. PMID: 31188909 Free PMC article. Review.
Replacing GHB with GBL in Recreational Settings: A New Trend in Chemsex.
Busardò FP, Gottardi M, Tini A, Minutillo A, Sirignano A, Marinelli E, Zaami S. Busardò FP, et al. Among authors: gottardi m. Curr Drug Metab. 2018;19(13):1080-1085. doi: 10.2174/1389200219666180925090834. Curr Drug Metab. 2018. PMID: 30251602 Review.
114 results